Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 3304
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA 600MG/200MG/245MG TBL FLM 30
0222766 EU/1/17/1263/001 efavirenze.pdf efavirenze.pdf J05AR06 R
EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL MYLAN 600MG/200MG/245MG TBL FLM 90(3X30)
0222765 EU/1/17/1222/002 efavirenze.pdf efavirenze.pdf J05AR06 R
EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL MYLAN 600MG/200MG/245MG TBL FLM 90
2500025 EU/1/17/1222/003 efavirenze.pdf efavirenze.pdf J05AR06 R
EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL MYLAN 600MG/200MG/245MG TBL FLM 30
0222764 EU/1/17/1222/001 efavirenze.pdf efavirenze.pdf J05AR06 R
EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL ZENTIVA 600MG/200MG/245MG TBL FLM 90(3X30)
0238239 EU/1/17/1210/002 efavirenze.pdf efavirenze.pdf J05AR06 R
EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL ZENTIVA 600MG/200MG/245MG TBL FLM 30
0222305 EU/1/17/1210/001 efavirenze.pdf efavirenze.pdf J05AR06 R
EFLORAN 5MG/ML INF SOL 1X100ML
0088214 42/ 828/92-S/C efloran.pdf efloran.pdf J01XD01 R
EFLUELDA INJ SUS ISP 5X0,7ML+5SJ
0239066 59/ 173/19-C efluelda.pdf efluelda.pdf J07BB02 R
EFLUELDA INJ SUS ISP 10X0,7ML
0239064 59/ 173/19-C efluelda.pdf efluelda.pdf J07BB02 R
EFLUELDA INJ SUS ISP 1X0,7ML
0239062 59/ 173/19-C efluelda.pdf efluelda.pdf J07BB02 R
EFLUELDA INJ SUS ISP 5X0,7ML
0239063 59/ 173/19-C efluelda.pdf efluelda.pdf J07BB02 R
EFLUELDA INJ SUS ISP 1X0,7ML+1SJ
0239065 59/ 173/19-C efluelda.pdf efluelda.pdf J07BB02 R
EFLUELDA INJ SUS ISP 10X0,7ML+10SJ
0239067 59/ 173/19-C efluelda.pdf efluelda.pdf J07BB02 R
EMTRICITABINE/TENOFOVIR DISOPROXIL ACCORDPHARMA 200MG/245MG TBL FLM 30X1
0227486 42/ 586/17-C emtricitab.pdf emtricitab.pdf J05AR03 R
EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA 200MG/245MG TBL FLM 28
0219198 EU/1/16/1151/001 emtricitab.pdf emtricitab.pdf J05AR03 R
EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA 200MG/245MG TBL FLM 30
0219199 EU/1/16/1151/002 emtricitab.pdf emtricitab.pdf J05AR03 R
EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA 200MG/245MG TBL FLM 84
0219200 EU/1/16/1151/003 emtricitab.pdf emtricitab.pdf J05AR03 R
EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA 200MG/245MG TBL FLM 90(3X30)
0219201 EU/1/16/1151/004 emtricitab.pdf emtricitab.pdf J05AR03 R
EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA D.D. 200MG/245MG TBL FLM 84
0222170 EU/1/17/1182/003 emtricitab.pdf emtricitab.pdf J05AR03 R
EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA D.D. 200MG/245MG TBL FLM 30
0222169 EU/1/17/1182/002 emtricitab.pdf emtricitab.pdf J05AR03 R

‹‹ ‹ 10 20 30 40 50 55 56 57 58 59 60 61 62 63 64 65 70 80 90 100 110 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 30. November 2021 at 00:09
Last update of price and payment data: 30. October 2021 at 01:12